A detailed history of Mraz, Amerine & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Mraz, Amerine & Associates, Inc. holds 17,358 shares of JNJ stock, worth $2.69 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
17,358
Previous 17,421 0.36%
Holding current value
$2.69 Million
Previous $2.55 Million 10.49%
% of portfolio
0.54%
Previous 0.55%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$145.48 - $167.38 $9,165 - $10,544
-63 Reduced 0.36%
17,358 $2.81 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $53,276 - $58,220
-369 Reduced 2.07%
17,421 $2.55 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $6,406 - $6,990
-44 Reduced 0.25%
17,790 $2.79 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $31,150 - $34,896
-200 Reduced 1.11%
17,834 $2.78 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $51,089 - $54,982
-331 Reduced 1.8%
18,034 $2.98 Million
Q1 2023

Apr 19, 2023

SELL
$151.05 - $180.26 $41,236 - $49,210
-273 Reduced 1.46%
18,365 $2.85 Million
Q4 2022

Jan 12, 2023

SELL
$160.2 - $179.79 $16,019 - $17,979
-100 Reduced 0.53%
18,638 $0
Q3 2022

Oct 25, 2022

BUY
$161.33 - $179.52 $5,969 - $6,642
37 Added 0.2%
18,738 $3.06 Million
Q2 2022

Jul 27, 2022

SELL
$168.19 - $186.01 $35,824 - $39,620
-213 Reduced 1.13%
18,701 $3.32 Million
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $26,352 - $29,238
-169 Reduced 0.89%
18,914 $3.24 Million
Q3 2021

Nov 08, 2021

SELL
$161.5 - $179.47 $32,300 - $35,894
-200 Reduced 1.04%
19,083 $3.08 Million
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $91,222 - $97,852
-572 Reduced 2.88%
19,283 $3.18 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $176,871 - $203,020
-1,290 Reduced 6.1%
19,855 $3.13 Million
Q3 2020

Nov 03, 2020

SELL
$140.38 - $153.83 $14,880 - $16,305
-106 Reduced 0.5%
21,145 $3.15 Million
Q2 2020

Jul 29, 2020

SELL
$128.81 - $155.51 $64,791 - $78,221
-503 Reduced 2.31%
21,251 $2.99 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $22,228 - $30,798
-200 Reduced 0.91%
21,754 $2.85 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $9,775 - $10,944
-77 Reduced 0.35%
21,954 $2.84 Million
Q2 2019

Aug 02, 2019

SELL
$131.15 - $144.24 $78,690 - $86,544
-600 Reduced 2.65%
22,031 $3.07 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $207,186 - $230,373
-1,648 Reduced 6.79%
22,631 $3.16 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $12,284 - $14,784
-100 Reduced 0.41%
24,279 $3.13 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $167,160 - $184,464
-1,400 Reduced 5.43%
24,379 $2.96 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $204,913 - $242,653
-1,638 Reduced 5.97%
25,779 $3.3 Million
Q4 2017

Feb 05, 2018

SELL
$131.22 - $143.62 $97,365 - $106,566
-742 Reduced 2.64%
27,417 $3.83 Million
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $3.65 Million - $3.81 Million
28,159
28,159 $3.66 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mraz, Amerine & Associates, Inc. Portfolio

Follow Mraz, Amerine & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mraz, Amerine & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mraz, Amerine & Associates, Inc. with notifications on news.